Skip to main content
. 2011 Nov 29;41(11):641–648. doi: 10.4070/kcj.2011.41.11.641

Table 4.

Changes in IVUS parameters and biomarkers

graphic file with name kcj-41-641-i004.jpg

nTAV: normalized total atheroma volume, Δ changes: post-treatment-baseline, PAV: percent atheroma volume, hs-CRP: high-sensitivity C-reactive protein, MMP-9: matrix metalloproteinase-9, sCD40L: soluble CD 40 ligand